vs
Side-by-side financial comparison of LINKBANCORP, Inc. (LNKB) and Phathom Pharmaceuticals, Inc. (PHAT). Click either name above to swap in a different company.
Phathom Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($57.6M vs $46.0M, roughly 1.3× LINKBANCORP, Inc.). On growth, Phathom Pharmaceuticals, Inc. posted the faster year-over-year revenue change (94.1% vs 7.3%). LINKBANCORP, Inc. produced more free cash flow last quarter ($23.8M vs $-167.0M).
LINKBANCORP, Inc. is a US-based bank holding company that offers comprehensive retail and commercial banking services to individual consumers, small businesses, and mid-sized enterprises. Its core offerings include deposit accounts, lending products, wealth management solutions, and digital banking services, primarily serving customers across regional markets in Pennsylvania.
Phathom Pharmaceuticals is a clinical-stage biopharmaceutical firm focused on developing and commercializing innovative therapies for gastrointestinal diseases. Its lead product candidates address acid-related disorders, inflammatory bowel disease, and other GI conditions, serving patients mainly across North America and Europe.
LNKB vs PHAT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $46.0M | $57.6M |
| Net Profit | $2.9M | — |
| Gross Margin | — | 86.7% |
| Operating Margin | 8.5% | — |
| Net Margin | 6.4% | — |
| Revenue YoY | 7.3% | 94.1% |
| Net Profit YoY | -61.2% | 71.6% |
| EPS (diluted) | $0.08 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $46.0M | $57.6M | ||
| Q3 25 | $44.8M | $49.5M | ||
| Q2 25 | $42.3M | $39.5M | ||
| Q1 25 | $53.4M | $28.5M | ||
| Q4 24 | $42.9M | $29.7M | ||
| Q3 24 | $42.9M | $16.4M | ||
| Q2 24 | $41.3M | $7.3M | ||
| Q1 24 | $40.5M | — |
| Q4 25 | $2.9M | — | ||
| Q3 25 | $7.8M | $-30.0M | ||
| Q2 25 | $7.4M | $-75.8M | ||
| Q1 25 | $15.3M | $-94.3M | ||
| Q4 24 | $7.6M | — | ||
| Q3 24 | $7.1M | $-85.6M | ||
| Q2 24 | $5.8M | $-91.4M | ||
| Q1 24 | $5.7M | — |
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 87.5% | ||
| Q2 25 | — | 87.2% | ||
| Q1 25 | — | 86.9% | ||
| Q4 24 | — | 87.1% | ||
| Q3 24 | — | 85.6% | ||
| Q2 24 | — | 81.2% | ||
| Q1 24 | — | — |
| Q4 25 | 8.5% | — | ||
| Q3 25 | 22.3% | -30.8% | ||
| Q2 25 | 22.4% | -151.7% | ||
| Q1 25 | 36.0% | -276.5% | ||
| Q4 24 | 22.6% | — | ||
| Q3 24 | 21.3% | -433.0% | ||
| Q2 24 | 18.0% | -1055.4% | ||
| Q1 24 | 18.1% | — |
| Q4 25 | 6.4% | — | ||
| Q3 25 | 17.5% | -60.5% | ||
| Q2 25 | 17.5% | -191.9% | ||
| Q1 25 | 28.7% | -330.7% | ||
| Q4 24 | 17.7% | — | ||
| Q3 24 | 16.5% | -523.3% | ||
| Q2 24 | 14.1% | -1248.6% | ||
| Q1 24 | 14.1% | — |
| Q4 25 | $0.08 | — | ||
| Q3 25 | $0.21 | $-0.41 | ||
| Q2 25 | $0.20 | $-1.05 | ||
| Q1 25 | $0.41 | $-1.31 | ||
| Q4 24 | $0.21 | — | ||
| Q3 24 | $0.19 | $-1.32 | ||
| Q2 24 | $0.16 | $-1.56 | ||
| Q1 24 | $0.15 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $52.3M | $130.0M |
| Total DebtLower is stronger | $177.3M | $209.1M |
| Stockholders' EquityBook value | $306.4M | $-438.2M |
| Total Assets | $3.1B | $259.1M |
| Debt / EquityLower = less leverage | 0.58× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $52.3M | $130.0M | ||
| Q3 25 | $194.2M | $135.2M | ||
| Q2 25 | $155.1M | $149.6M | ||
| Q1 25 | $220.2M | $212.3M | ||
| Q4 24 | $166.1M | $297.3M | ||
| Q3 24 | $191.2M | $334.7M | ||
| Q2 24 | $181.7M | $276.2M | ||
| Q1 24 | $172.3M | — |
| Q4 25 | $177.3M | $209.1M | ||
| Q3 25 | $102.3M | $207.1M | ||
| Q2 25 | $102.3M | $205.1M | ||
| Q1 25 | $102.7M | $203.2M | ||
| Q4 24 | $112.5M | $201.4M | ||
| Q3 24 | $102.4M | $175.7M | ||
| Q2 24 | $102.3M | $174.4M | ||
| Q1 24 | $102.2M | — |
| Q4 25 | $306.4M | $-438.2M | ||
| Q3 25 | $305.5M | $-422.5M | ||
| Q2 25 | $298.0M | $-405.8M | ||
| Q1 25 | $294.1M | $-338.4M | ||
| Q4 24 | $280.2M | $-253.6M | ||
| Q3 24 | $277.4M | $-187.1M | ||
| Q2 24 | $271.4M | $-233.8M | ||
| Q1 24 | $268.2M | — |
| Q4 25 | $3.1B | $259.1M | ||
| Q3 25 | $3.1B | $240.3M | ||
| Q2 25 | $2.9B | $250.2M | ||
| Q1 25 | $2.9B | $294.2M | ||
| Q4 24 | $2.9B | $378.3M | ||
| Q3 24 | $2.9B | $387.0M | ||
| Q2 24 | $2.9B | $319.4M | ||
| Q1 24 | $2.8B | — |
| Q4 25 | 0.58× | — | ||
| Q3 25 | 0.33× | — | ||
| Q2 25 | 0.34× | — | ||
| Q1 25 | 0.35× | — | ||
| Q4 24 | 0.40× | — | ||
| Q3 24 | 0.37× | — | ||
| Q2 24 | 0.38× | — | ||
| Q1 24 | 0.38× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $25.3M | $-166.8M |
| Free Cash FlowOCF − Capex | $23.8M | $-167.0M |
| FCF MarginFCF / Revenue | 51.7% | -290.0% |
| Capex IntensityCapex / Revenue | 3.2% | 0.4% |
| Cash ConversionOCF / Net Profit | 8.59× | — |
| TTM Free Cash FlowTrailing 4 quarters | $55.3M | $-328.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $25.3M | $-166.8M | ||
| Q3 25 | $23.6M | $-14.1M | ||
| Q2 25 | $6.3M | $-62.7M | ||
| Q1 25 | $2.6M | $-84.9M | ||
| Q4 24 | $25.4M | $-266.8M | ||
| Q3 24 | $14.0M | $-63.6M | ||
| Q2 24 | $6.4M | $-70.7M | ||
| Q1 24 | $-771.0K | — |
| Q4 25 | $23.8M | $-167.0M | ||
| Q3 25 | $23.2M | $-14.1M | ||
| Q2 25 | $6.1M | $-62.8M | ||
| Q1 25 | $2.2M | $-84.9M | ||
| Q4 24 | $22.6M | $-266.9M | ||
| Q3 24 | $13.1M | $-63.6M | ||
| Q2 24 | $6.3M | $-70.8M | ||
| Q1 24 | $-1.2M | — |
| Q4 25 | 51.7% | -290.0% | ||
| Q3 25 | 51.8% | -28.6% | ||
| Q2 25 | 14.5% | -159.0% | ||
| Q1 25 | 4.2% | -297.9% | ||
| Q4 24 | 52.6% | -899.8% | ||
| Q3 24 | 30.5% | -389.0% | ||
| Q2 24 | 15.3% | -966.2% | ||
| Q1 24 | -3.0% | — |
| Q4 25 | 3.2% | 0.4% | ||
| Q3 25 | 0.8% | 0.1% | ||
| Q2 25 | 0.4% | 0.2% | ||
| Q1 25 | 0.7% | 0.1% | ||
| Q4 24 | 6.7% | 0.5% | ||
| Q3 24 | 2.1% | 0.3% | ||
| Q2 24 | 0.1% | 0.6% | ||
| Q1 24 | 1.1% | — |
| Q4 25 | 8.59× | — | ||
| Q3 25 | 3.01× | — | ||
| Q2 25 | 0.85× | — | ||
| Q1 25 | 0.17× | — | ||
| Q4 24 | 3.35× | — | ||
| Q3 24 | 1.97× | — | ||
| Q2 24 | 1.10× | — | ||
| Q1 24 | -0.13× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
